Why acute liver failure or acute liver injury patients showed relatively preserved ADAMTS13-specific activity compared to patients with decompensated cirrhosis and acute-on-chronic liver failure is unclear but may reflect the fundamentally different pathological changes driving acute liver failure compared with hepatic decompensation in patients with cirrhosis. This evidence concerns the gene ADAMTS13 and acute-on-chronic liver failure.